May 19, 2020 / 12:11 PM / 17 days ago

BRIEF-Revance Reports Agreement To Acquire HintMD

May 19 (Reuters) - Revance Therapeutics Inc:

* REVANCE ANNOUNCES AGREEMENT TO ACQUIRE HINTMD AND ITS PROPRIETARY FINTECH PLATFORM FOR AESTHETIC PRACTICES

* REVANCE THERAPEUTICS INC - ALL-STOCK TRANSACTION. REVANCE CASH RUNWAY REMAINS INTO 2023

* REVANCE THERAPEUTICS INC - REVANCE HAS AGREED TO PAY HINTMD’S SHAREHOLDERS A TOTAL OF 8.54 MILLION SHARES OF REVANCE COMMON STOCK

* REVANCE THERAPEUTICS - NOT PROVIDING U.S. GAAP GUIDANCE UNTIL ACQUISITION ACCOUNTING IS COMPLETE

* REVANCE THERAPEUTICS INC - EXPECTS 2020 NON-GAAP OPERATING EXPENSE TO REMAIN BETWEEN $220 TO $230 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below